Results 91 to 100 of about 1,198,128 (191)

Stem cell therapy in systemic sclerosis. [PDF]

open access: yesClin Rheumatol
Sakkas LI   +4 more
europepmc   +1 more source

Comparison of Intracardiac Cell Transplantation: Autologous Skeletal Myoblasts Versus Bone Marrow Cells

open access: yesCirculation, 2003
Richard B. Thompson   +7 more
semanticscholar   +1 more source

Consecutive fecal microbiota transplantation for metabolic dysfunction-associated steatotic liver disease: a randomized controlled trial. [PDF]

open access: yesGut Microbes
Groenewegen B   +10 more
europepmc   +1 more source

Impact of pre‐transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation

open access: yesCancer, 2017
A. El-Jawahri   +44 more
semanticscholar   +1 more source

Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report

open access: yesCancer, 2017
J. Schriber   +21 more
semanticscholar   +1 more source

Causes of and Solutions to Mitochondrial Disorders: A Literature Review. [PDF]

open access: yesInt J Mol Sci
Belousova V   +9 more
europepmc   +1 more source

Autologous Hematopoietic Stem Cell Transplantation for Paraneoplastic Cerebellar Degeneration. [PDF]

open access: yesNeurol Neuroimmunol Neuroinflamm
Guerra V   +14 more
europepmc   +1 more source

Multiple myeloma: Role of autologous transplantation

open access: yes, 2020
Autologous stem cell transplantation (ASCT) has been the mainstay of multiple myeloma (MM) treatment for approximately 30 years. Although the continuous introduction of novel agents in the armamentarium against MM has questioned its value, ASCT remains a backbone treatment for fit MM patients. However, there is no unanimous approach for several aspects
openaire   +3 more sources

Home - About - Disclaimer - Privacy